ScienceDex / Researcher record
Alfredo Andres Celedon
- Scanogen, Inc. (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Top 10% Funded
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $3,785,644 | 4 | #1,759 |
| 2025 | $4,754,717 | 5 | #1,531 |
| 2026 | $2,768,815 | 3 | #6,911 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected4 records
- FY20255 records
- FY20263 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10098991Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Alfredo Andres Celedon as a PI. Multi-PI records show the full award amount for context.
- $1Maward amount
- $999.9Kaward amount
- $999.9Kaward amount
- 5R01AI175063-02R01Contact PIRapid ID and AST Directly from Whole Blood Using Single Molecule Detection$785.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Alfredo Andres Celedon as a PI.
FY2024 award administered by Scanogen, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardScanogen, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1759
- 2024Entered Top 25% NationallyRanked #1759
- 2024Entered Top 10% NationallyRanked #1759
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
- 2026$10M Cumulative Funding